Advertisement
Letter to the Editor| Volume 103, P126-127, September 2022

Serum cystatin C, cystatin C level change and risk of atrial fibrillation

  • Odong Christopher
    Affiliations
    Cardiology Department, First Affiliated Hospital of Sun Yat-Sen University, 58 Zhongshan 2nd Road, Guangzhou 510080, China

    NHC Key Laboratory of Assisted Circulation, Sun Yat-Sen University, China
    Search for articles by this author
  • Yiquan Huang
    Affiliations
    Cardiology Department, First Affiliated Hospital of Sun Yat-Sen University, 58 Zhongshan 2nd Road, Guangzhou 510080, China

    NHC Key Laboratory of Assisted Circulation, Sun Yat-Sen University, China
    Search for articles by this author
  • Zhenyu Xiong
    Affiliations
    Cardiology Department, First Affiliated Hospital of Sun Yat-Sen University, 58 Zhongshan 2nd Road, Guangzhou 510080, China

    NHC Key Laboratory of Assisted Circulation, Sun Yat-Sen University, China
    Search for articles by this author
  • Xiaodong Zhuang
    Correspondence
    Corresponding authors at: Cardiology Department, First Affiliated Hospital of Sun Yat-Sen University, 58 Zhongshan 2nd Road, Guangzhou 510080, China.
    Affiliations
    Cardiology Department, First Affiliated Hospital of Sun Yat-Sen University, 58 Zhongshan 2nd Road, Guangzhou 510080, China

    NHC Key Laboratory of Assisted Circulation, Sun Yat-Sen University, China
    Search for articles by this author
  • Xinxue Liao
    Correspondence
    Corresponding authors at: Cardiology Department, First Affiliated Hospital of Sun Yat-Sen University, 58 Zhongshan 2nd Road, Guangzhou 510080, China.
    Affiliations
    Cardiology Department, First Affiliated Hospital of Sun Yat-Sen University, 58 Zhongshan 2nd Road, Guangzhou 510080, China

    NHC Key Laboratory of Assisted Circulation, Sun Yat-Sen University, China
    Search for articles by this author
Published:July 20, 2022DOI:https://doi.org/10.1016/j.ejim.2022.07.012
Serum cystatin C, cystatin C level change and risk of atrial fibrillation
Previous ArticleAssociation of tenofovir and entecavir use with prognosis after surgical resection for hepatitis B virus-related hepatocellular carcinoma
      Dear Editor,
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to European Journal of Internal Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Chung M.K.
        • Eckhardt L.L.
        • Chen L.Y.
        • Ahmed H.M.
        • Gopinathannair R.
        • Joglar J.A.
        • et al.
        Lifestyle and risk factor modification for reduction of atrial fibrillation: a scientific statement from the American Heart Association.
        Circulation. 2020; 141: e750-ee72
        View in Article
        • Ding Y.
        • Liu L.
        • Chen Z.
        • Li H.
        • Pan Y.
        • Wang J.
        • et al.
        Serum cystatin C predicts stroke clinical outcomes at 1 year independent of renal function.
        Front Neurol. 2021; 12676872
        View in Article
        • Angeli F.
        • Verdecchia P.
        • Savonitto S.
        • Arraiz G.
        • Zaninotto M.
        • Broccatelli A.
        • et al.
        Cystatin C and risk of mortality among patients undergoing percutaneous coronary intervention.
        EuroIntervention. 2015; 11: 757-764
        View in Article
        • Salgado J.V.
        • Souza F.L.
        • Salgado B.J.
        How to understand the association between cystatin C levels and cardiovascular disease: imbalance, counterbalance, or consequence?.
        J Cardiol. 2013; 62: 331-335
        View in Article
        • Zou L.X.
        • Sun L.
        • Nicholas S.B.
        • Lu Y.
        • K S.S.
        • Hua R.
        Comparison of bias and accuracy using cystatin C and creatinine in CKD-EPI equations for GFR estimation.
        Eur J Intern Med. 2020; 80: 29-34
        View in Article
        • Rehm M.
        • Rothenbacher D.
        • Iacoviello L.
        • Costanzo S.
        • Tunstall-Pedoe H.
        • Fitton C.A.
        • et al.
        Chronic kidney disease and risk of atrial fibrillation and heart failure in general population-based cohorts: the BiomarCaRE project.
        ESC Heart Fail. 2022; 9: 57-65
        View in Article
        • Rothenbacher D.
        • Rehm M.
        • Iacoviello L.
        • Costanzo S.
        • Tunstall-Pedoe H.
        • Belch J.J.F.
        • et al.
        Contribution of cystatin C- and creatinine-based definitions of chronic kidney disease to cardiovascular risk assessment in 20 population-based and 3 disease cohorts: the BiomarCaRE project.
        BMC Med. 2020; 18: 300
        View in Article
      8. The Atherosclerosis Risk in Communities (ARIC) study: design and objectives. the ARIC investigators.
        Am J Epidemiol. 1989; 129: 687-702
        View in Article
        • Wang W.
        • Yuan R.
        • Korantzopoulos P.
        • Xu G.
        • Cui X.
        • Li G.
        • et al.
        Cystatin C and risk of atrial fibrillation in elderly hypertensive patients without chronic kidney disease.
        Int J Cardiol. 2016; 212: 262-264
        View in Article
        • Jin L.L.
        • You L.
        • Xie R.Q.
        Value of cystatin C in predicting atrial fibrillation recurrence after radiofrequency catheter ablation.
        J Geriatr Cardiol. 2018; 15: 725-731
        View in Article

      Article info

      Publication history

      Published online: July 20, 2022
      Accepted: July 15, 2022
      Received: July 6, 2022

      Identification

      DOI: https://doi.org/10.1016/j.ejim.2022.07.012

      Copyright

      © 2022 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX